Can I read Phase II Study of Temozolomide and Veliparib on EtoBox?

Phase II Study of Temozolomide and Veliparib by sina.jj2000 is a document available to read on EtoBox.

What is Phase II Study of Temozolomide and Veliparib about?

This document outlines a randomized, double-blinded Phase II study investigating the efficacy of temozolomide in combination with the PARP inhibitor ABT-888 versus placebo in patients with relapsed-sensitive or refractory small-cell lung cancer. The primary endpoint is progression-free survival at four months, with the hypothesis that the combination treatment will improve outcomes compared to placebo. The study involves multiple institutions and includes specific eligibility criteria for patient enrollment

Author

sina.jj2000

Language

EN